Linked Life Data

18489745

Source:http://linkedlifedata.com/resource/pubmed/id/18489745

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2008-5-29
pubmed:abstractText
A 45-year-old white male presented to our department with postoperative recurrence of gastrointestinal poorly differentiated neuroendocrine carcinoma manifesting as lymph node dissemination and a solitary implantation metastasis in the rectovesical pouch. Following disease progression on chemotherapy, the patient was treated with radiotherapy using either a conventional daily treatment or an accelerated hyperfractionated protocol to separate sites of disease progression. Using serial CT scan assessment, changes in cross-sectional area of the separately treated metastatic lesions were evaluated for determination of therapy response. The accelerated hyperfractionated radiotherapy appeared to limit the rate of tumor growth to a greater degree than the conventional fractionation schedule. Of uttermost importance, in this palliative setting, the patient completed the intensified radiotherapy regimens with acceptable acute toxicity. Given the proliferative capacity of poorly differentiated neuroendocrine carcinomas of the gastrointestinal tract, radiotherapy may be a therapeutic supplement to chemotherapy, which represents the main treatment option in this tumor entity. Importantly, tumors with a capacity for rapid proliferation and regeneration may be particularly sensitive to the use of intensified fractionation protocols in clinical radiotherapy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-11144795, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-15150595, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-15153416, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-15226341, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-15234027, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-15965493, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-16448551, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-16819503, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-16950362, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-17482301, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-17505000, http://linkedlifedata.com/resource/pubmed/commentcorrection/18489745-17762759
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1748-717X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Highly proliferative neuroendocrine carcinoma - influence of radiotherapy fractionation on tumor response.
pubmed:affiliation
Division of Cancer Medicine and Radiotherapy, The Norwegian Radium Hospital, Rikshospitalet University Hospital, 0310 Oslo, Norway. a.h.ree@medisin.uio.no
pubmed:publicationType
Journal Article, Case Reports